SUPERIOR GAINS IN BONE MINERAL DENSITY AND ESTIMATED STRENGTH AT THE HIP FOR ROMOSOZUMAB COMPARED WITH TERIPARATIDE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TRANSITIONING FROM BISPHOSPHONATE THERAPY: RESULTS OF THE PHASE 3 OPEN-LABEL STRUCTURE STUDY

被引：0

作者：

Langdahl, B. ^{[1
]}

Libanati, C. ^{[2
]}

Crittenden, D. ^{[3
]}

Bolognese, M. ^{[4
]}

Brown, J. ^{[5
,6
]}

Daizadeh, N. ^{[3
]}

Dokoupilova, E. ^{[7
]}

Engelke, K. ^{[8
]}

Finkelstein, J. ^{[9
]}

Genant, H. ^{[10
]}

Goemaere, S. ^{[11
]}

Hyldstrup, L. ^{[12
]}

Jodar-Gimeno, E. ^{[13
]}

Keaveny, T. ^{[14
]}

Kendler, D. ^{[15
]}

Lakatos, P. ^{[16
]}

Maddox, J. ^{[3
]}

Malouf, J. ^{[17
]}

Massari, F. ^{[18
]}

Molina, J. ^{[19
]}

Ulla, M. ^{[20
]}

Grauer, A. ^{[3
]}

机构：

[1] Aarhus Univ Hosp, Aarhus, Denmark

[2] UCB Pharma, Brussels, Belgium

[3] Amgen Inc, Thousand Oaks, CA 91320 USA

[4] Bethesda Hlth Res Ctr, Bethesda, MD USA

[5] Laval Univ, Quebec City, PQ, Canada

[6] CHU Quebec CHUL, Res Ctr, Quebec City, PQ, Canada

[7] Med Plus, Uherske Hradiste, Czech Republic

[8] BioClinica Inc, Hamburg, Germany

[9] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[10] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA

[11] Ghent Univ Hosp, Ghent, Belgium

[12] Hvidovre Univ Hosp, Hvidovre, Denmark

[13] Hosp Univ Quiron, Serv Endocrinol, Madrid, Spain

[14] Univ Calif Berkeley, Berkeley, CA 94720 USA

[15] Univ British Columbia, Vancouver, BC, Canada

[16] Semmelweis Univ, Dept Med, Budapest, Hungary

[17] Univ Autonoma Barcelona, Barcelona, Spain

[18] Inst Invest Metab, Buenos Aires, DF, Argentina

[19] Reumalab Ctr Integral Reumatol, Medellin, Colombia

[20] Inst Latinoamer Invest Med, Cordoba, Argentina

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.1163

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0100

引用

页码：92 / 93

页数：2

共 23 条

[1] SUPERIOR GAINS IN BONE MINERAL DENSITY AND ESTIMATED STRENGTH AT THE HIP FOR ROMOSOZUMAB COMPARED WITH TERIPARATIDE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TRANSITIONING FROM BISPHOSPHONATE THERAPY: RESULTS OF THE PHASE 3 OPEN-LABEL STRUCTURE STUDY
Malouf, J.
Langdahl, B.
Libanati, C.
Crittenden, D. B.
Bolognese, M. A.
Brown, J. P.
Daizadeh, N. S.
Dokoupilova, E.
Engelke, K.
Finkelstein, J. S.
Genant, H. K.
Goemaere, S.
Hyldstrup, L.
Jodar-Gimeno, E.
Keaveny, T. M.
Kendler, D.
Lakatos, P.
Maddox, J.
Massari, F. E.
Molina, J. F.
Ulla, M. R.
Grauer, A.
OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S40 - S41
[2] Superior Gains in Bone Mineral Density and Estimated Strength at the Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of a Phase 3, Open-Label Clinical Trial
Langdahl, B.
Libanati, C.
Crittenden, D. B.
Bolognese, M. A.
Brown, J. P.
Daizadeh, N. S.
Engelke, K.
Genant, H. K.
Goemaere, S.
Hyldstrup, Lars
Jodar-Gimeno, E.
Keaveny, T. M.
Kendler, D.
Lakatos, P.
Maddox, J.
Malouf, J.
Massari, F. E.
Molina, J. F.
Ulla, M. R.
Grauer, A.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[3] Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Langdahl, Bente L.
Libanati, Cesar
Crittenden, Daria B.
Bolognese, Michael A.
Brown, Jacques P.
Daizadeh, Nadia S.
Dokoupilova, Eva
Engelke, Klaus
Finkelstein, Joel S.
Genant, Harry K.
Goemaere, Stefan
Hyldstrup, Lars
Jodar-Gimeno, Esteban
Keaveny, Tony M.
Kendler, David
Lakatos, Peter
Maddox, Judy
Malouf, Jorge
Massari, Fabio E.
Fernando Molina, Jose
Rosa Ulla, Maria
Grauer, Andreas
LANCET, 2017, 390 (10102): : 1585 - 1594
[4] EIGHT YEARS OF CONTINUED ODANACATIB THERAPY FOR POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: RESULTS FROM AN OPEN-LABEL EXTENSION TO A PHASE IIB STUDY
Rizzoli, R.
Rodriguez Portales, J. A.
Benhamou, C. L.
Halse, J.
Miller, P. D.
Reid, I.
Dasilva, C.
Kroon, R.
Leung, A.
Gurner, D.
OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S123 - S124
[5] Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
Senn, C.
Guenther, B.
Popp, A. W.
Perrelet, R.
Hans, D.
Lippuner, K.
OSTEOPOROSIS INTERNATIONAL, 2014, 25 (07) : 1945 - 1951
[6] Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
C. Senn
B. Günther
A. W. Popp
R. Perrelet
D. Hans
K. Lippuner
Osteoporosis International, 2014, 25 : 1945 - 1951
[7] Comparison of Romosozumab and Teriparatide Effects on Cortical and Trabecular Bone Using 3D Modeling From DXA Images in Postmenopausal Women Transitioning From Bisphosphonate Therapy
Lewiecki, E. Michael
Betah, Donald
Humbert, Ludovic
Libanati, Cesar
Oates, Mary
Shi, Yifei
Winzenrieth, Renaud
Ferrari, Serge
Omura, Fumitoshi
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 26 - 26
[8] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
Watts, N. B.
Dore, R. K.
Baim, S.
Mitlak, B.
Hattersley, G.
Wang, Y.
Rozental, T. D.
LeBoff, M. S.
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 55 - 61
[9] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
N.B. Watts
R.K. Dore
S. Baim
B. Mitlak
G. Hattersley
Y. Wang
T.D. Rozental
M.S. LeBoff
Osteoporosis International, 2021, 32 : 55 - 61
[10] Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis: Results from the ACTIVExtend Phase 3 Trial
Watts, Nelson B.
Dore, Robin K.
Baim, Sanford
Hattersley, Gary
Williams, Greg
Wang, Yamei
Rozental, Tamara D.
Leboff, Meryl S.
JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 292 - 292

← 1 2 3 →